Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14837120 | 0.79 | — | — | |
| SCHEMBL8463017 | 0.71 | — | — | |
| SCHEMBL18316532 | 0.67 | — | — | |
| SCHEMBL2400553 | 0.65 | — | — | |
| SCHEMBL779499 | 0.65 | HSD17B10 (0.38) | CYP2C19 | |
| SCHEMBL4676872 | 0.63 | — | — | |
| SCHEMBL317280 | 0.63 | — | — | |
| SCHEMBL13259143 | 0.63 | — | — | |
| SCHEMBL98480 | 0.63 | — | — | |
| SCHEMBL2105245 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2369670-B1 | Non-aqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | UBE INDUSTRIES (JP) | 2016-03-23 | — | — | EP | claimed |
| EP-1650826-B1 | NONAQUEOUS ELECTROLYTIC SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY USING SAME | UBE INDUSTRIES (JP) | 2013-05-01 | — | — | EP | claimed |
| EP-2369670-A1 | Non-aqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | Ube Industries, Ltd. (JP) | 2011-09-28 | — | — | EP | claimed |
| US-20100239919-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY USING SAME | UBE INDUSTRIES, LTD. (JP) | 2010-09-23 | — | — | US | claimed |
| US-11444324-B2 | Electrolyte for secondary battery, secondary battery, battery pack, electric vehicle, electric power storage system, electric tool and electronic device | MURATA MANUFACTURING CO., LTD. (JP) | 2022-09-13 | — | — | US | disclosed |
| US-20200058959-A1 | ELECTROLYTE FOR SECONDARY BATTERY, SECONDARY BATTERY, BATTERY PACK, ELECTRIC VEHICLE, ELECTRIC POWER STORAGE SYSTEM, ELECTRIC TOOL AND ELECTRONIC DEVICE | MURATA MANUFACTURING CO., LTD. (JP) | 2020-02-20 | — | — | US | disclosed |
| EP-2863469-B1 | NONAQUEOUS ELECTROLYTE SECONDARY CELL AND METHOD FOR USING SAME | MITSUBISHI CHEM CORP (JP) | 2017-11-22 | — | — | EP | disclosed |
| EP-2369670-B1 | Non-aqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | UBE INDUSTRIES (JP) | 2016-03-23 | — | — | EP | disclosed |
| EP-2863469-A1 | NONAQUEOUS ELECTROLYTE SECONDARY CELL AND METHOD FOR USING SAME | Mitsubishi Chemical Corporation (JP) | 2015-04-22 | — | — | EP | disclosed |
| CN-104025366-A | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery | MITSUBISHI CHEM CORP | 2014-09-03 | — | — | CN | disclosed |
| US-8722255-B2 | Non-aqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | UBE INDUSTRIES, LTD. (JP) | 2014-05-13 | — | — | US | disclosed |
| US-8530080-B2 | Nonaqueous electrolyte solution and lithium secondary battery using same | UBE INDUSTRIES, LTD. (JP) | 2013-09-10 | — | — | US | disclosed |
| US-7629085-B2 | sulfur-containing acid ester and an alkyne-containing compound; excellent battery characteristics in cycle performance, electric capacity and storage property; e.g. 2-propynyl methyl carbonate and 1,3-propanesultone | UBE INDUSTRIES, LTD. (JP) | 2009-12-08 | — | — | US | disclosed |
| CN-100559648-C | Nonaqueous electrolytic solution and the lithium secondary battery that uses it | UBE INDUSTRIES (JP) | 2009-11-11 | — | — | CN | disclosed |
| US-20090053598-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY USING SAME | MU IONIC SOLUTIONS CORPORATION (JP) | 2009-02-26 | — | — | US | disclosed |
| CN-101107745-A | Nonaqueous electrolyte solution and lithium secondary battery using same | UBE INDUSTRIES (JP) | 2008-01-16 | — | — | CN | disclosed |
| US-20070231707-A1 | Nonaqueous Electrolytic Solution and Lithium Secondary Battery | MU IONIC SOLUTIONS CORPORATION (JP) | 2007-10-04 | — | — | US | disclosed |
| EP-1772924-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND LITHIUM SECONDARY BATTERY | Ube Industries, Ltd. (JP) | 2007-04-11 | — | — | EP | disclosed |
| US-20060177742-A1 | Nonaqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | MU IONIC SOLUTIONS CORPORATION (JP) | 2006-08-10 | — | — | US | disclosed |
| EP-1650826-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY USING SAME | Ube Industries, Ltd. (JP) | 2006-04-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11444324-B2 | Electrolyte for secondary battery, secondary battery, battery pack, electric vehicle, electric power storage system, electric tool and electronic device | FOXM1, CHRM2, ESR1 | CYP2C19 1639/4885 |
| US-20200058959-A1 | ELECTROLYTE FOR SECONDARY BATTERY, SECONDARY BATTERY, BATTERY PACK, ELECTRIC VEHICLE, ELECTRIC POWER STORAGE SYSTEM, ELECTRIC TOOL AND ELECTRONIC DEVICE | FOXM1, CHRM2, ESR1 | CYP2C19 1639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.